Stockscreener 앱 받기
486.00
0.50%
-2.43
전일 마감가:
$488.43
열려 있는:
$490.25
하루 거래량:
168.09K
Relative Volume:
0.24
시가총액:
$20.93B
수익:
$3.08B
순이익/손실:
$1.24B
주가수익비율:
18.98
EPS:
25.6108
순현금흐름:
$1.07B
1주 성능:
+2.35%
1개월 성능:
+17.01%
6개월 성능:
+53.97%
1년 성능:
+28.53%
1일 변동 폭
$484.35
$490.30
1주일 범위
$466.72
$492.62
52주 변동 폭
$266.98
$492.62
유나이티드 테라퓨틱스 Stock (UTHR) Company Profile
명칭
United Therapeutics Corp
전화
(301) 608-9292
주소
1000 SPRING ST, SILVER SPRING, MD
UTHR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
486.00 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
|
ZTS
Zoetis Inc
|
128.18 | 56.27B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.42 | 45.87B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.78 | 43.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.89 | 30.20B | 16.70B | -157.13M | 1.19B | -0.1446 |
유나이티드 테라퓨틱스 Stock (UTHR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Wells Fargo | Underweight |
| 2025-09-26 | 개시 | RBC Capital Mkts | Outperform |
| 2025-06-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-07-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-02-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2022-12-06 | 개시 | UBS | Buy |
| 2022-12-05 | 개시 | Goldman | Sell |
| 2022-10-11 | 개시 | Morgan Stanley | Overweight |
| 2022-09-20 | 재확인 | BofA Securities | Underperform |
| 2022-09-19 | 재개 | Wedbush | Outperform |
| 2022-02-11 | 개시 | BTIG Research | Neutral |
| 2021-07-14 | 업그레이드 | Argus | Hold → Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-02-01 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-06-25 | 재확인 | H.C. Wainwright | Neutral |
| 2020-03-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-02-27 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-01-31 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-03 | 개시 | BofA/Merrill | Underperform |
| 2019-08-01 | 업그레이드 | Jefferies | Underperform → Hold |
| 2019-08-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-09 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2018-08-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | 재확인 | Barclays | Underweight |
| 2018-01-18 | 재개 | Credit Suisse | Underperform |
| 2017-12-27 | 재확인 | Wedbush | Outperform |
| 2017-04-27 | 재확인 | Wedbush | Outperform |
| 2017-03-30 | 개시 | UBS | Sell |
| 2017-03-16 | 개시 | Credit Suisse | Underperform |
모두보기
유나이티드 테라퓨틱스 주식(UTHR)의 최신 뉴스
Is United Therapeutics Still a Hidden Gem After 34.9% Share Price Surge in 2025? - simplywall.st
What is the fair value of United Therapeutics Corporation stock nowEarnings Overview Report & High Yield Equity Trading Tips - moha.gov.vn
United Therapeutics Executives Sell Shares Worth Over $15 Million - TradingView
[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan
Chmn Rothblatt Files To Sell 4,000 Of United Therapeutics Corp [UTHR] - TradingView
Chmn Rothblatt Sells 8,000 ($3.8M) Of United Therapeutics Corp [UTHR] - TradingView
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
United Therapeutics stock hits all-time high at 485.43 USD - Investing.com
United Therapeutics Corporation (UTHR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Heatmap analysis for United Therapeutics Corporation and competitorsJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Why United Therapeutics Corporation stock is trending among retail tradersMarket Trend Review & Precise Buy Zone Tips - newser.com
How United Therapeutics Corporation (UTH) stock trades after earningsBear Alert & AI Powered Buy/Sell Recommendations - newser.com
Understanding United Therapeutics Corporation’s price movementMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Jefferies reiterates Buy rating on United Therapeutics stock, cites strong growth - Investing.com
How United Therapeutics Corporation stock benefits from global expansionEarnings Trend Report & Trade Opportunity Analysis Reports - newser.com
Pres Benkowitz Sells 22,500 ($10.6M) Of United Therapeutics Corp [UTHR] - TradingView
CFO Edgemond Sells 21,000 ($9.9M) Of United Therapeutics Corp [UTHR] - TradingView
Chmn Rothblatt Sells 8,000 ($3.7M) Of United Therapeutics Corp [UTHR] - TradingView
How United Therapeutics Corporation (UTH) stock correlates with oil marketsWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
United Therapeutics stock hits all-time high of $479.78 By Investing.com - Investing.com South Africa
United Therapeutics stock hits all-time high of $479.78 - Investing.com
United Therapeutics posts record revenue but misses Q3 earnings expectations - MSN
Can technical indicators confirm United Therapeutics Corporation’s reversal2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com
Will United Therapeutics Corporation benefit from macro trends2025 Market Trends & Detailed Earnings Play Strategies - newser.com
How United Therapeutics Corporation (UTH) stock reacts to stronger dollarRecession Risk & Risk Controlled Stock Alerts - newser.com
Rothblatt (United Therapeutics) sells $4.7m in UTHR stock By Investing.com - Investing.com Canada
United Therapeutics Executives Sell Shares - TradingView
United Therapeutics Executives Sell Shares Worth Over $13 Million - TradingView
CFO Edgemond Sells 21,000 ($9.5M) Of United Therapeutics Corp [UTHR] - TradingView
3 Reasons Investors Love United Therapeutics (UTHR) - Finviz
United Therapeutics (UTHR): Stock Up 44.4%, Strong Growth & Cash FlowNews and Statistics - IndexBox
Is United Therapeutics Corporation (UTH) stock a top dividend aristocrat candidateJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com
Will United Therapeutics Corporation stock rally after Fed decisionsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - MSN
United Therapeutics Corp’s Earnings Call Highlights Growth and Innovation - MSN
United Therapeutics CorporationCommon Stock (Nasdaq:UTHR) Stock Quote - Markets Financial Content
P/E Ratio Insights for United Therapeutics - Benzinga
Is United Therapeutics Corp Gaining or Losing Market Support? - Sahm
United Therapeutics Corporation (UTHR) Stock Forecasts - Yahoo! Finance Canada
UBS Maintains United Therapeutics (UTHR) Buy Recommendation - Nasdaq
United Therapeutics (NASDAQ:UTHR) CEO Sells $1,753,200.00 in Stock - MarketBeat
United Therapeutics CFO Sells Over $9 Million in Company Stock - TradingView
유나이티드 테라퓨틱스 (UTHR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
유나이티드 테라퓨틱스 주식 (UTHR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| EDGEMOND JAMES | CFO AND TREASURER |
Nov 24 '25 |
Option Exercise |
146.03 |
21,000 |
3,066,630 |
29,142 |
| EDGEMOND JAMES | CFO AND TREASURER |
Nov 24 '25 |
Sale |
473.64 |
21,000 |
9,946,544 |
8,142 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Nov 24 '25 |
Option Exercise |
137.07 |
22,500 |
3,084,146 |
12,000 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Nov 24 '25 |
Sale |
473.66 |
22,500 |
10,657,280 |
0 |
| MAHON PAUL A | EVP & GENERAL COUNSEL |
Nov 26 '25 |
Option Exercise |
135.42 |
11,000 |
1,489,620 |
47,781 |
| MAHON PAUL A | EVP & GENERAL COUNSEL |
Nov 26 '25 |
Sale |
486.06 |
11,000 |
5,346,701 |
36,781 |
0.38%
0.17%
자본화:
|
볼륨(24시간):